PHARMACEUTICAL PRODUCT DEVELOPMENT INC Operating Income
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Operating Income of $65.42 million for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2011-11-02
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC operating income (loss) for the quarter ending 2011-09-30 was $65.42M, a 15.10% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC operating income (loss) for the quarter ending 2011-06-30 was $57.15M, a 42.57% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC operating income (loss) for the quarter ending 2011-03-31 was $52.45M, a 89.47% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC operating income (loss) for the quarter ending 2010-12-31 was $62.85M, a 66.16% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC operating income (loss) for fiscal 2010 was $187.45M, a 12.53% decline from fiscal 2009.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC operating income (loss) for fiscal 2009 was $214.31M, a 24.11% decline from fiscal 2008.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC operating income (loss) for fiscal 2008 was $282.40M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2011-09-30 | $65.42M 10-Q · filed 2011-11-02 | $122.56M derived: sum of 2 quarters · filed 2011-11-02 | $175.01M 10-Q · filed 2011-11-02 | $237.87M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-06-30 | $57.15M 10-Q · filed 2011-08-04 | $109.59M 10-Q · filed 2011-08-04 | $172.45M derived: sum of 3 quarters · filed 2011-08-04 | $229.28M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-03-31 | $52.45M 10-Q · filed 2011-05-03 | $115.30M derived: sum of 2 quarters · filed 2011-05-03 | $172.13M derived: sum of 3 quarters · filed 2011-11-02 | $212.22M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-12-31 | $62.85M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $119.69M derived: sum of 2 quarters · filed 2011-11-02 | $159.77M derived: sum of 3 quarters · filed 2011-11-02 | $187.45M 10-K · filed 2011-02-25 |
| 2010-09-30 | $56.84M 10-Q · filed 2011-11-02 | $96.92M derived: sum of 2 quarters · filed 2011-11-02 | $124.60M 10-Q · filed 2011-11-02 | $162.43M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-06-30 | $40.08M 10-Q · filed 2011-08-04 | $67.77M 10-Q · filed 2011-08-04 | $105.59M derived: sum of 3 quarters · filed 2011-08-04 | $157.22M derived: sum of 4 quarters · filed 2011-08-04 |
| 2010-03-31 | $27.68M 10-Q · filed 2011-05-03 | $65.51M derived: sum of 2 quarters · filed 2011-05-03 | $117.14M derived: sum of 3 quarters · filed 2011-05-03 | $175.40M derived: sum of 4 quarters · filed 2011-05-03 |
| 2009-12-31 | $37.83M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $89.45M derived: sum of 2 quarters · filed 2011-02-25 | $147.72M derived: sum of 3 quarters · filed 2011-02-25 | $214.31M 10-K · filed 2011-02-25 |
| 2009-09-30 | $51.63M 10-Q · filed 2010-11-05 | $109.89M derived: sum of 2 quarters · filed 2010-11-05 | $176.48M 10-Q · filed 2010-11-05 | |
| 2009-06-30 | $58.26M 10-Q · filed 2010-08-06 | $124.85M 10-Q · filed 2010-08-06 | ||
| 2008-12-31 | $282.40M 10-K · filed 2011-02-25 |